Advanced search
Publication Cover
Expert Opinion on Therapeutic Patents Volume 4, 1994 - Issue 11
Submit an article Journal homepage
3
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Patent Update Cardiovascular & Renal: Nitric oxide synthase inhibitors: recent advances

Giorgio Bertolini Italfarmaco Research Center, via dei Lavoratori 54, 20092 Cinisello Balsamo, Milan, Italy
&
Mario Aquino Italfarmaco Research Center, via dei Lavoratori 54, 20092 Cinisello Balsamo, Milan, Italy
Pages 1339-1345 | Published online: 03 Mar 2008

References to Primary Literature

  • MONCADA S, PALMER RMJ, HIGGS EA: Nitric oxide: physi-ology, pathophysiology and pharmacology. Pharmacol.Rev. (1991) 43: 109–142. Thorough review of pharmacological action of nitric oxide.
  • CORBETT JA, TILTON RG, CHANG K, HASAN KS, IDO Y,WANG JL, SWEETLAND MA, LANCASTER JR, \WILLIAMSON JR, McDANIEL ML: Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dys-function. Diabetes (1992) 41: 552–556.
  • BRUHWYLER J, CHLEIDE E, LIEGEOIS JF, CARREER F: Nitricoxide: A new messenger in the brain. Neurosci. Biobehav. Rev. (1993) 17: 373–384.
  • MONCADA 5, IEGGS A: The L-arginine-nitric oxide path-way. N. Engl. J. Med. (1993) 329: 2002–2012.
  • GARTHWAITE J: Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci. (1991) 14: 60–67.
  • STUEHR DJ, GROSS SS, SAKUMA I, LEVI R, NATHAN CF: Activated murine macrophages secrete a metabolite of arginkte with the bioactivity of endothelium-derived relaxing factor and the chemical reactivity of nitric oxide. J. Exp. Med. (1989) 169: 1011–1020.
  • CORBETT JA, WANG JL, HUGHES JH, WOLF BA, SWEET LAND MA, LANCASTER JR, MCDANIEL ML: Nitric oxide and cyclic GMP formation induced by interleukin 1 fl in islets of Langerhans. Evidence for an effector role of nitric oxide in islet dysfunction. Biochem.J. (1992) 287: 229–235.
  • SZABO C, MITCHELL JA, THIEMERMANN C, VANE JR: Nitricoxide-mediated hyporeactivity to noradrenaline pre-cedes the induction of nitric oxide synthase in endo-toxin shock. Br. J. Pharmacot (1993) 108: 786–792.
  • DAWSON VL, DAWSON TM, LONDON ED, BREDT DS,SNYDER SH: Nitric oxide mediates glutamate neuro-toxicity in primary cortical cultures. Proc. Natl. Acad. Sci. USA (1991) 88: 6368–6371.
  • ROGERS NE, IGNARRO LJ: Constitutive nitric oxide syn-thase from cerebellum is reversibly inhibited by nitric oxide formed from L-arginine. Biochem. Biophys. Res. Commun. (1992) 189: 242–249.
  • GRISCAVAGE JM, ROGERS NE, SHERMAN MP, IGNARRO LJ:Inducible nitric oxide synthase from a rat alveolar macrophage cell line is inhibited by nitric oxide. J. immuna (1993) 151: 6329–6337.
  • VALIANCE P, LEONE A, CALVER A, COLLIER), MONCADAS: Accumulation of an endogenous inhibitor of nitricoxide synthesis in chronic renal failure. Lancet (1992) 339: 572–575. First report of the presence of an endogenous NOS inhibitor.
  • FICICLING S, LEONE A, NUSSEY A, VALIANCE P, WHITLEY G: Synthesis of NG;NG-dimethylarginine by human cells. Endothelium (1993) 1: 137–140.
  • McALL1STER RJ, WHITLEY G, VALIANCE P: Effects of guanidino und uremic compounds on nitric oxide pathways. Kidney Int. (1994) 45: 737–742.
  • YANG X, CAI B, SCIACCA RR, CANNON PJ: Inhibition ofinducible nitric oxide synthase in macrophages by oxidized low-density lipoproteins. Circ. Res. (1994) 74: 318–328.
  • PALMER RMJ, ASTHON DS, MONCADA S: Vascular endo-thelial cells synthesize nitric oxide from L-arginine. Nature (1988) 333: 664–666.
  • WHITTEN JP, McDONALD IA: Inhibition of nitric oxidebiosynthesis. Curr. Opin. Ther. Patents (1992) 2: 713–726.
  • McCALL TB, FEELISCH M, PALMER RMJ, MONCADA S:
  • •Identification of N-iminoethyl-L-ornithine as an irre-versible inhibitor of nitric oxide synthase in phagocytic cells. Br. J. Pharmacol. (1991) 102: 234–238.
  • Report of the first real selective inducible NOS inhibitor.
  • LAMBERT LE, FRENCH JF, WHITTEN JP, BARON BM, MCDONALD IA: Characterization of cell selectivity of two novel inhibitors of nitric oxide synthesis. Eur. Pharmacol. (1992) 216: 131–134.
  • NARAYANAN K, GRIFFITH OW: Synthesis of L-thiocitrilline, L-homothiocitrulline and S-methyl-L- thiocitrealline: a new class of potent nitric oxide synthase inhibitors. J. Med. Chem. (1994) 37: 885–887. Interesting design of new NOS inhibitors using information on the active site of the enzyme.
  • NARAYANAN K, SPACK L, HAYWARD M, GRIFFITH OW:S-methyl-L-thiodtrulline: a potent inhibitor of nitric oxide synthase with strong pressor activity in vivo. EASEL ?J. (1994) 8: A360.
  • COWART M, ICERWIN JF, KOHLHAAS KL, KOWALUK EA,ALEXANDER KM: Synthesis of phosphorus-containing amino acid analogs as inhibitors of nitric oxide syn-thase. 24th National Medicinal Chemistry Symposium. Salt Lake City, Utah. (1994). Abstr. 40.
  • MAY RC, KELLY RA, MITCH WE: Pathophysiology of uremia, in the kidney, Brenner BM, Rector FC (Eds.), (5th ed. ), Philadelphia, Saunders, (1991), 1997–2018.
  • BROWNLEE M, VLASSARA H, KOONEY A, ULRICH P, CERAMI A: Aminoguankline prevents diabetes-induced arterial wall protein cross-linking. Science (1986) 232: 1629–1632.
  • HASAN K, HEESEN BJ, CORBETT JA, McDANIEL ML, CHANG K, ALLISON W, WOLFFENBUTTEL BHR, WILLIAMSON JR, TILTON RG: Inhibition of nitric oxide formation by guanidines. Eur. J. Pharmacol. (1993) 249: 101–106.
  • SCHOTTHarr CA, VETROVSKY P, STOCLET JC: Cationic amino acids inhibit the effects of L-arginine in rat aorta ex-posed to lipopolysaccharide. Eur. J. Pharmacol. (1993) 236: 155–157.
  • MOORE PK, WALLACE P, GAFFEN Z, HART SL, BABBEDGE
  • •RC: 7-nitro indazole, an inhibitor of nitric oxide syn-thase, exhibits antinociceptive activity in the mouse without increasing blood pressure. Br. J. Pharmacol. (1993) 108: 296–297. First report of heterocyclic based NOS inhibitors.
  • BABBEDGE RC, BLAND-WARD SL, HART SL, MOORE PK:Inhibition of rat cerebellar nitric oxide synthase by 7-nitro indazole and related substituted indazoles. Br.J. Pharmacol. (1993) 110: 225–228.
  • DWYER MA, BREDT DS, SNYDER SH: Nitric oxide syn-thase: irreversible inhibition by L-NG-nitro arginine in brainin vitro and in vivo. Biochem. Biophys. Res. Commun. (1991) 176: 1136–1141.
  • MOORE PK, OLUYOMI AO, BABBEDGE RC, WALLACE P,HART SL: L-N6-nitro arginine methyl ester exhibits an-tinociceptive activity in the mouse. Br. J. Pharmacol. (1991) 102: 198–202.
  • MOORE PK, WALLACE P, GAFFEN Z, HART SL, BABBEDGERC: Characterization of novel nitric oxide synthase Inhibitor 7-nitro indazole and related indazoies: anti-nociceptive and cardiovascular effects. Br. J. Pharmacol. (1993) 110: 219–224.
  • MEDHURST AD, GREENLEES C, PARSONS AA, SMITH SJ:Nitric oxide synthase inhibitors 7- and 6-nitroindazole relax smooth muscle in vitro. Eur. J. Pharmacol. (1994) 256: R5–R6.
  • HArrom R, INOUE R, SASE K, EIZAWA H, KOSUGA K, AOYAMA T, MASAYASU H, KAWAI C, SASAYAMA S, YUI Y: Preferential inhibition of inducible nitric oxide syn-thase by ebselen. Eur.J. Pharmacol. (1994) 267: R1–R2.
  • SZABO C, THIEMERMANN C, VANE JR: Dihydropyridine antagonists and agonists of calcium channels inhibit the induction of nitric oxide synthase by endotoxin in cultured macrophages. Biochem. Biophys. Res. Commun. (1993) 196: 825–828.
  • SZABO C, THIEMERMANN C, C(7U CC, VANE JR: Dilly-dropyridine calcium channel modulators inhibit the Induction of NO synthase and prevent the inhibition of cellular respiration caused by endotoxin in J774. 2 macrophages. Br. J. Pharmacol. (1994) 112: 419P.
  • ZINGARELLI B, CARNUCCIO R, DI ROSA M: Cloricromene inhibks the induction of nitric oxide synthase. Eur. J. Pharmacol. (1993) 243: 107–111.
  • HI) j, LEE JH, EL-FAKAHANY EE: Inhibition of neuralnitric oxide synthase by antipsychotic drugs. Psycho-pharmacology (1994) 114: 161–166.
  • COHEN J, SILVA A: NO inhibitors and septic shock. Lancet(1992) 339: 751.

References to Patent Literature

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.